Liang Y, Wei H Y, Chen R M, Zhang Z X, Cheng X R, Tao N, Wang C L, Yang Y, Xin Y, Fan X, Zhang X X, Liu G L, Cheng S Q, Zhu M, Du H W, Sun Y, Chen L Q, Cui L W, Luo X P
Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Hubei Key Laboratory of Pediatric Genetic Metabolic and Endocrine Rare Diseases, Wuhan 430030, China.
Department of Endocrinology, Genetics and Metabolism, Children's Hospital Affiliated to Zhengzhou University, Zhenzhou 450000, China.
Zhonghua Er Ke Za Zhi. 2024 Oct 2;62(10):962-968. doi: 10.3760/cma.j.cn112140-20240523-00359.
To investigate the clinical characteristics and management status of children with Turner syndrome (TS) in China. As a cross-sectional study, 1 089 TS patients were included in the database of the National Collaborative Alliance for the Diagnosis and Treatment of Turner Syndrome from August 2019 to November 2023. Clinical characteristics (growth development, sexual development, organ anomalies, etc.), karyotypes, auxiliary examinations, and treatments were collected and analyzed. Among the 1 089 TS cases, 809 were recorded karyotypes. The karyotype distribution was as follows: 45, X in 317 cases (39.2%), X chromosome structural variants (including partial deletions of p or q arm, ring chromosome, and marker chromosome) in 89 cases (11.0%), 45, X/46, XX mosaicism in 158 cases (19.5%), mosaicism with X chromosome structural variants in 209 cases (25.8%), and presence of Y chromosome material in 36 cases (4.4%). Among the 824 TS cases, the age of diagnosis was 9.7(6.4, 12.2) years, with a height standard deviation score (HtSDS) of -3.1±1.2. Five hundred and fifty three cases underwent growth hormone (GH) stimulation test, and 352 cases (63.7%) had GH peak values <10 μg/L and 75.9% (577/760) had low IGF1 levels, with IGF1 SDS ≤-2 accounting for 38.2% (290 cases). Among 471 cases aged ≥8 years, 132 cases (28.0%) showed spontaneous sexual development (mean bone age (11.0±1.7) years), 10 cases had spontaneous menarche (mean bone age (12.0±2.2) years), and 2 cases had regular menstrual cycles. Common physical features included cubitus valgus (311 cases (28.5%)), neck webbing (188 cases (17.2%)), low posterior hairline (185 cases (17.0%)), shield chest (153 cases (14.0%)), high arched palate (127 cases (11.6%)), short fourth metacarpal (43 cases (3.9%)), and spinal abnormalities (38 cases (3.5%)). Congenital cardiovascular and urogenital anomalies occurred in 91 cases (19.4%) and 66 cases (12.0%)respectively. Abdominal ultrasound in 33 cases (7.2%) indicated fatty liver, hepatomegaly, intrahepatic bile duct stones, and splenomegaly. Among 23 cases undergoing oral glucose tolerance test (OGTT) test, 2 were diagnosed with diabetes mellitus and 4 with impaired glucose tolerance. Following diagnosis, 669 cases (80.7%) received rhGH treatment at a chronological age of (9±4) years and bone age of (8.3±3.2) years. Additionally, 112 cases (19.4%) received sex hormone replacement therapy starting at the age of (14±4) years and bone age of (12.6±1.2) years. The karyotypes of 45, X and mosaicism were most common in Chinese children with TS. The clinical manifestations were mainly short stature and gonadal dysplasia. However, a few TS children could be in the normal range of height, and some cases among those aged of ≥8 years old had spontaneous sexual development. Some exhibited physical features, congenital cardiovascular and urogenital anomalies, and dysfunction of the hypothalamic-pituitary-IGF1 axis. Moreover, a few of them developed impaired glucose tolerance and diabetes mellitus. Following diagnosis, most of the patients received rhGH treatment, and a few of them received sex hormone replacement therapy.
调查中国特纳综合征(TS)患儿的临床特征及治疗现状。作为一项横断面研究,2019年8月至2023年11月期间,1089例TS患者被纳入特纳综合征诊断与治疗全国协作联盟数据库。收集并分析了临床特征(生长发育、性发育、器官异常等)、核型、辅助检查及治疗情况。1089例TS病例中,809例记录了核型。核型分布如下:45,X共317例(39.2%),X染色体结构变异(包括p或q臂部分缺失、环状染色体及标记染色体)共89例(11.0%),45,X/46,XX嵌合体共158例(19.5%),X染色体结构变异嵌合体共209例(25.8%),存在Y染色体物质共36例(4.4%)。824例TS病例中,诊断年龄为9.7(6.4, 12.2)岁,身高标准差评分(HtSDS)为-3.1±1.2。553例进行了生长激素(GH)刺激试验,352例(63.7%)GH峰值<10 μg/L,75.9%(577/760)胰岛素样生长因子1(IGF1)水平低,IGF1 SDS≤-2占38.2%(290例)。471例≥8岁患者中,132例(28.0%)出现自发性性发育(平均骨龄(11.0±1.7)岁),10例出现自然月经初潮(平均骨龄(12.0±2.2)岁),2例月经周期规律。常见体征包括肘外翻(311例(28.5%))、蹼颈(188例(17.2%))、后发际低(185例(17.0%))、盾状胸(153例(14.0%))、高腭弓(127例(11.6%))、第四掌骨短(43例(3.9%))及脊柱异常(38例(3.5%))。先天性心血管和泌尿生殖系统异常分别发生在91例(19.4%)和66例(12.0%)。33例(7.2%)腹部超声提示脂肪肝、肝肿大、肝内胆管结石及脾肿大。23例进行口服葡萄糖耐量试验(OGTT),2例诊断为糖尿病,4例糖耐量受损。确诊后,669例(80.7%)在实际年龄(9±4)岁、骨龄(8.3±3.2)岁时接受重组人生长激素(rhGH)治疗。此外,112例(19.4%)在年龄(14±4)岁、骨龄(12.6±1.2)岁时开始接受性激素替代治疗。45,X及嵌合体核型在中国TS患儿中最为常见。临床表现主要为身材矮小和性腺发育不良。然而,少数TS患儿身高可在正常范围内,部分≥8岁患儿有自发性性发育。部分患儿有体征、先天性心血管和泌尿生殖系统异常以及下丘脑 - 垂体 - IGF1轴功能障碍。此外,少数患儿出现糖耐量受损和糖尿病。确诊后,大多数患者接受rhGH治疗,少数患者接受性激素替代治疗。